Patient Files: Spinal muscular atrophy (SMA)
Cheryl Yoder shares her family’s experiences with this rare, genetic disorder
PharmaTimes Magazine
PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What's more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
View more from the latest edition
Branching out
Pharma companies have improved how they engage with healthcare providers during COVID-19, says Accenture’s Brad Michel
Decentralising research
Revolutionising clinical trials with wearables and digital endpoints
Reinventing patient engagement
Lessons from the Patient Partnership Index conference
Artificial inventors
The question of artificial intelligence as an inventor – and what it means for drug discovery
Keeping trial data alive
Insight into the conduct of clinical trials and managing data amid the pandemic
Maintaining cross-border medicines supply
Updated guidelines from the European Medicines Agency for pharmaceuticals marketing authorisation holders offer new clarity on what they must do to maintain continuity of supply of UK-registered products in Europe once the Brexit transition period ends.
Rethinking cancer detection
If we are to truly beat cancer, we need to pay as much attention to detecting it as we do treating it
